Close To Six In 10 Individuals Quit GLP-1 Drugs Before Achieving Meaningful Weight Loss

Nearly six in 10 individuals (58%) stop using glucagon-like peptide-1 (GLP-1) agonist drugs for weight loss before reaching a “clinically meaningful” health benefit, according to research by Blue Health Intelligence® (BHI®). GLP-1 agonists are medications that help lower blood sugar levels and promote weight loss. According to outside research, those on GLP-1 drugs should complete at least 12 weeks of continuous treatment to be able to achieve clinically meaningful weight loss that will positively impact their health. These results were observed in GLP-1 users regardless of the type of GLP-1 medication treatment used . . .